Curriculum Vitae. Luci A. Power. Education: M.S. Hospital Pharmacy, 1977 Northeastern University, Boston, Massachusetts

Transcription

1 Curriculum Vitae Luci A. Power Education: M.S. Hospital Pharmacy, 1977 Northeastern University, Boston, Massachusetts Licensure: California, 1978 Experience: B.S. Pharmacy, 1969 Northeastern University, Boston, Massachusetts Massachusetts, 1969 June 2005: Senior Pharmacist, Manager, Parenteral Support Services, Pharmaceutical Services, January 1997: Senior Pharmacist, Manager, IV Additive Service, Pharmaceutical Services, March 1986: Senior Pharmacy Consultant, Power Enterprises, Pharmacy Systems Specialists, San Francisco, CA. November 1983: Assistant Director, Pharmaceutical Services, Inpatient Operational Services, November 1983: Pharmacist Specialist in Intravenous Additives and Chemotherapy October 1981: Assistant Director, Pharmaceutical Services, Inpatient Special Services, October 1980: Senior Pharmacist; Supervisor Intravenous Additive Service, August 1979: Staff II Pharmacist, Intravenous Additive Service, 1

2 July 1977: Pharmacy Pediatric Coordinator; Supervisor Pediatric Satellite and Central Support Services, New England Medical Center Hospital, Boston, MA 1975: Clinical Instructor in Pharmacy, Massachusetts College of Pharmacy, Boston, MA. October 1975: Staff Pharmacist New England Medical Center Hospital Boston, MA. 1973: Staff Pharmacist Saint Vincent Hospital Worcester, MA. Honors: 1977: Rho Chi Honor Society Phi Kappa Phi Honor Society. 1976: Massachusetts Society of Hospital Pharmacists, Staff Pharmacist of the Year. Professional Society Activities: American Society of Hospital Pharmacists Reviewer, American Journal of Hospital Pharmacy 1990: Programming Associate, ASHP Annual Meeting Boston, Massachusetts 2000: Programming Associate, ASHP Midyear Clinical Meeting Las Vegas, Nevada : Golden Gate Society of Hospital Pharmacists 1985: President : California Society of Hospital Pharmacists : Director, Board of Directors 1986: Committee of Membership, Chair Seminar 87 Continuing Education Committee 2

3 Massachusetts Society of Hospital Pharmacists Professional Activities: 2005: Lead author. ASHP Guidelines on Handling Hazardous Drugs. Published Am J Health-System Pharm. Jun 15, : Contributing author. NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings. NIOSH Publication No , September : Group Leader, Work Practices Small Group, National Institutes of Occupational Safety and Health (NIOSH) Working Group on Handling Hazardous Drugs. 2000: Meeting Programming Associate for American Society of Health Systems Pharmacists, Midyear Clinical Meeting, Las Vegas, NV. Safe Handling of Cytotoxic and Hazardous Drugs: Presentation of Proposed Changes to the ASHP Technical Assistance Bulletin on Handling Cytotoxic Drugs. Winter : Guest lecturer, University of California, San Francisco, School of Pharmacy, Clinical Oncology Elective. Error Prevention in Screening Chemotherapy Orders and Safe Handling of Chemotherapy Compounding. Spring : Guest lecturer, University of California, San Francisco, School of Pharmacy, CP 113 Introduction to Pharmacy Practice. Topic: Preparation of Hazardous Drugs Caution in Compounding. Fall : Guest lecturer, University of California, San Francisco, School of Pharmacy, CP 121 Parenteral Products. Topic: Chemotherapy and Biohazards Caution in Compounding. September 1994: Advisor and guest lecturer, University of California, San Francisco, School of Pharmacy, CP 121 Parenteral Products. February 1993: Reviewer, Occupational Safety and Health Administration, for OSHA Instruction CPL B CH-4, Chapter 24: Hazardous Drug Handling. March 1993: Reviewer, Occupational Safety and Health Administration, for OSHA Instruction Training and Education Directive 1.15; Section V: Chapter 3, Controlling Occupational Exposure to Hazardous Drugs; published in September : Principal author, American Society of Hospital Pharmacist, revised Technical Assistance Bulletin (TAB) on handling cytotoxic and hazardous drugs. January 1990: Technical advisor and reviewer, American Society of Hospital Pharmacists videotape, Safe Handling of Cytotoxic and Hazardous Drugs. January 1986: Advisor and reviewer, Occupation Safety and Health Administration, for OSHA Instructional Publication 9-1.1, work Practice Guidelines for Personnel Dealing with Cytotoxic (Antineoplastic) Drugs. February 1986: Consultant and technical advisor, American Society of Hospital 3

4 January October Pharmacists videotape, Safe Handling of Cytotoxic Drugs revised edition. 1985: Collaborator, American society of hospital Pharmacists Technical Assistance Bulletin on handling cytotoxic drugs in hospitals. 1983: Script consultant and technical advisor, American Society of Hospital Pharmacists videotape, Safe Handling of Cytotoxic Drugs. Professional Presentations: 2006: Hazardous Drug Guidelines: Strategies for Implementing Work Practice Controls. Presented at the ONS 31 th Annual Congress, Boston, MA. 2006: Limiting Exposure to Hazardous Drugs: Working Within the Guidelines. Presented at the ONS 31 th Annual Congress, Boston, MA. 2005: ASHP 2005 Guidelines on Handling Hazardous Drugs: Key Points and Update on Recommendations. Presented at the American Society of Health Systems Pharmacists Midyear Clinical Meeting, Las Vegas, NV. November April 2005: Handling Hazardous Drugs: Creating a Safer Workplace. Presented at the ONS Institutes of Learning, Phoenix, AZ. 2005: New Approaches in Safe Handling of Hazardous Drugs. Presented at the ONS 30 th Annual Congress, Orlando, FL. 2004: Overview of the NIOSH Alert on Hazardous Drugs. Presented at the American Society of Health Systems Pharmacists Midyear Clinical Meeting, Orlando, FL. October 2004: Control of Exposures to Hazardous Drugs: Engineering Controls, Ventilation, Biological Safety Cabinets, Personal Protective Equipment, Gloves, and Work Practices Duane Hammond, NIOSH; Thomas Connor, NIOSH; Luci Power, UCSF. Presented at the NIOSH Conference, NIOSH Alert on Reducing Occupational Exposures to Hazardous Drugs in Healthcare: Converting Theory to Practice. San Antonio, TX. October 2004: Work Practice Controls in the Preparation of Hazardous Drugs. Presented at the NIOSH Conference, NIOSH Alert on Reducing Occupational Exposures to Hazardous Drugs in Healthcare: Converting Theory to Practice. San Antonio, TX. April 2004: New Approaches in Safe Handling of Hazardous Drugs. Presented at the ONS 29 th Annual Congress, Anaheim, CA. September July 2002: Safe Handling of Hazardous Drugs. Canadian Association of Pharmacy Technicians (C.A.P.T.) Conference Alberta, Canada. 2002: Safe Handling of Hazardous Drugs. National Pharmaceutical Technicians Association (NPTA) Annual Meeting, Las Vegas, NV. 2001: Contemporary Issues in the Safe Handling of Cytotoxic Agents. 4

5 September November March February November June February June March Exhibitor s Theater, presented at the American Society of Hospital Pharmacists, Midyear Clinical Meeting, New Orleans, LA. 2001: The Next Generation: New Cytotoxic Handling Perspectives: Current Thinking and Changes in Practice. Presented at the MD Anderson Cancer Center 23rd Annual Pharmacy Symposium on Cancer Chemotherapy, Houston, TX. 2001: Safe Handling of Cytotoxic Agents. Presented at the ONS 26th Annual Congress, San Diego, CA. 2000: Safe Handling of Cytotoxic and Hazardous Drugs: Presentation of Proposed Changes to the ASHP Technical Assistance Bulletin on Handling Cytotoxic Drugs. Presented at the American Society of Health Systems Pharmacists, Midyear Clinical Meeting, Las Vegas, NV. 1999: Safe Handling of Cytotoxics: The Rules have Changed. Exhibitor s Theater, presented at the American Society of Hospital Pharmacists Midyear Clinical Meeting, Orlando, FL. 1999: Safe Handling of Cytotoxics: The Rules have Changed. Exhibitor s Theater, presented at the American Society of Hospital Pharmacists Midyear Clinical Meeting, Orlando, FL. 1999: Safe Handling of Cytotoxics: The Rules have Changed. Presented at the Oncology Nurses Forum, Salt Lake City, UT. 1995: Safe Handling of Cytotoxic and Other Hazardous Drugs, Overview and Update: Have we made any progress?, presented at Cedar- Sinai Medical Center, Los Angeles, CA 1993: Chemotherapy Handling and Aseptic Techniques: Is chemotherapy compatible with QC, QA, and GMP?, presented at the Michigan Pharmacists Association 1993 Interim Meeting, Dearborn, MI. 1991: Chemotherapy Safety: Issues for the 90 s, International roundtable discussion held in conjunction with InterHospital, Dusseldorf, Germany. 1990: Safe Handling of Cytotoxic and Other Hazardous Drugs, presented at the Quatra County Society of Hospital Pharmacists meeting, San Jose, CA. 1990: Safe Handling of Cytotoxic Agents a Hands-on Workshop, presented at the American Society of Hospital Pharmacists Annual Meeting, Boston, MA. 1990: Safe Handling of Cytotoxic and Other Hazardous Drugs, presented at Desert Samaritan Hospital, Costa Mesa, AZ. 1989: Highlights of the Technical Assistance bulletin (TAB) on Handling Cytotoxic and Hazardous Drugs, presented at the American Society of Hospital Pharmacists Annual Meeting, Nashville TN. 1989: Highlights of the Technical Assistance bulletin (TAB) on Handling Cytotoxic and Hazardous Drugs, presented at the American Society of Hospital Pharmacists Annual Meeting, Nashville TN. 1989: Issues and Concerns Regarding BioHazard and Cytotoxic Materials, presented at the VHA Supply company 1989 national meeting, Phoenix, AZ. 5

6 March October October September Publications: 1988: A Review of California State Board of Pharmacy Parenteral Therapy Regulations, presented at the California Pharmaceutical Association sponsored Western Home Health Care Conference, Garden Grove, CA. 1987: Cytotoxics and Other hazardous Drugs: Defining the Risks of handling and Identifying Methods of Management, presented at the 75 th Annual national Safety Council congress & Exposition, Chicago, IL. 1986: Cytotoxic Drugs: Safe Management Through a Team Approach. Nationwide live satellite teleconference sponsored by the American Hospital Association, Chicago, IL. 1984: Handling Cytotoxic Drugs: Literature, Legislation, Litigation Is Safety Winning? Presented at the California Society of Hospital Pharmacists Seminar 84. San Francisco, CA. 1983: Pharmacy Compliance with State Regulatory Agency Citation for Unsafe Practices in the Workplace: Regulated Handling of Parenteral Cytotoxic Drugs, management case study, American society of Hospital Pharmacists Midyear Clinical Meeting, Atlanta, GA. 1982: Quality Assurance Program for Intravenous Admixture Service: Focus on End-Product Testing and Corrective Action, poster presentation, American society of Hospital Pharmacists Midyear Clinical Meeting, Los Angeles, CA. Power LA. Handling hazardous drugs: Are our safety programs effective? Am J Health-Syst Pharm. 2006; 63:1130. Editorial. Power LA. Controlling exposure to hazardous drugs. Hosp Pharm Europe. 2006; 26: Power LA. Demand clean vials.am J Health Syst Pharm. 2005; 62:471. Editorial. Connor TH, Anderson RQ, Sessink PJM, Broadfield L, Power LA. Surface contamination with antineoplastic agents in six cancer treatment centers in the United States and Canada. Am J Hosp Pharm. 1999; 56: Power LA. Controlling occupational exposure to hazardous drugs. Hosp Pharm Report. October, Power LA, Anderson RQ, Cortopassi R et al. Update on safe handling of hazardous drugs: the advice of experts. Am J Hosp Pharm. 1990; 47: Power LA. Danger of handling oncological agents. In: Becker CE, Coye KJ, eds. Cancer Prevention: Strategies in the Workplace. Washington: Hemisphere; Lovejoy N, Power L, Flessel P et al. Mutagenicity in urine of hospital workers who prepare and administer chemotherapy agents. EMS abstracts. 1985; 7(3):5. 6

7 7 Stolar MH, Power LA. Risk management: safe handling of cytotoxic drugs in hospitals. Quality Review bulletin. 1984; 10(7): Power LA. Handling cytotoxics: minimizing risks. Frankly Speaking. 1984; 3(3):1-6. Power LA, Stolar MH. Handling mutagenic drugs. Lancet. 1984; I: Stolar MH, Power LA. Viele CS. Recommendations for handling cytotoxic drugs in hospitals. Am J Hosp Pharm. 1983; 40: Power LA. Regulated handling of parenteral antineoplastic agents. Particulate and Microbial Control. 1983; 40: